Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LillyDirect Foundayo vs Risen Labs

LillyDirect Foundayo
Graded #165

Higher grade

vs+10
Risen Labs
Graded #403

Lower grade

The verdict

LillyDirect Foundayo takes it — 67.2/100 to 57.2/100.

LillyDirect Foundayo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLillyDirect Foundayo +27
72
45
Dose & formulationLillyDirect Foundayo +19
59
40
Clinical oversightRisen Labs +1
78
79
Labs & monitoringRisen Labs +12
52
64
FulfillmentLillyDirect Foundayo +12
80
68
Contract termsEven
55
55
LillyDirect Foundayo · left barRisen Labs · right bar

The numbers

MetricLillyDirect FoundayoRisen Labs
WeighScore67.2/10057.2/100
GradeCC
Scorecard rank#165#403
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageAll 50 states2 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
LillyDirect Foundayo

Graded #165 · C

Strengths

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Where it loses points

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow
Risen Labs

Graded #403 · C

Strengths

  • Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
  • Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
  • Focused clinical intake covering weight loss, men's health, and hormone protocols

Where it loses points

  • GLP-1 pricing is not published; it appears only after you complete the clinical intake
  • Available only to patients in New York and Colorado
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No LegitScript certification is displayed on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard